Literature DB >> 8051339

Short cycles of very low calorie diet in the therapy of obese type II diabetes mellitus.

C M Rotella1, B Cresci, E Mannucci, S M Rizzello, G Colzi, G Galli, S Giannini, G Messeri, F Piani, R Vannini.   

Abstract

Very Low Calorie Diet (VLCD) is known to induce not only weight loss, but also an improvement of metabolic control, in obese type II diabetics. In order to evaluate the therapeutical efficacy of cycles of VLCD shorter than those previously described, 29 obese type II diabetics and 31 obese nondiabetic subjects were entered as inpatients and prescribed a 450 kcal/day diet for 15 days. Metabolic results obtained were similar to those achieved with longer cycles of VLCD, showing that 15 days are sufficient to induce a BMI decrease in diabetic (BMI from 35.3 +/- 4.8 to 33.3 +/- 4.6 after VLCD) and nondiabetic patients (BMI from 40.5 +/- 7.4 to 38.1 +/- 7.2 after VLCD), a desired fall of blood glucose levels and the decrease of daily insulin needs in insulin-treated patients. Glucagon tests were performed before and after VLCD in order to study possible modifications of insulin secretion. Although we did not observe any significant increase of C-peptide basal or peak levels (nM/ml) either in diabetic (basal levels before VLDC: 1.2 +/- 0.4 and peak levels 2.4 +/- 0.7; basal after VLCD 1.23 +/- 0.6 and peak 2.6 +/- 0.7) and nondiabetic patients (basal levels before VLDC 1.0 +/- 0.3 and peak levels 2.5 +/- 0.4; basal after VLCD 0.9 +/- 0.3 and peak 2.4 +/- 0.6). The rise of the C-peptide/glycemia ratio is an index of an improvement of insulin biological activity, which could be partly responsible for the therapeutical effects of VLCD.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051339     DOI: 10.1007/BF03347709

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  26 in total

1.  Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects.

Authors:  R R Wing; M D Marcus; R Salata; L H Epstein; S Miaskiewicz; E H Blair
Journal:  Arch Intern Med       Date:  1991-07

2.  Cooperativity in ligand binding: a new graphic analysis.

Authors:  P De Meyts; J Roth
Journal:  Biochem Biophys Res Commun       Date:  1975-10-27       Impact factor: 3.575

3.  Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus.

Authors:  P J Savage; L J Bennion; E V Flock; M Nagulesparan; D Mott; J Roth; R H Unger; P H Bennett
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

4.  Very-low-calorie protein diets.

Authors:  P Felig
Journal:  N Engl J Med       Date:  1984-03-01       Impact factor: 91.245

5.  The safety and efficacy of a controlled low-energy ('very-low-calorie') diet in the treatment of non-insulin-dependent diabetes and obesity.

Authors:  J M Amatruda; J F Richeson; S L Welle; R G Brodows; D H Lockwood
Journal:  Arch Intern Med       Date:  1988-04

6.  Changes in plasma lipoproteins accompanying diet therapy in obese diabetics.

Authors:  B V Howard; P J Savage; M Nagulesparan; L J Bennion; M Davis; P H Bennett
Journal:  Atherosclerosis       Date:  1979-08       Impact factor: 5.162

7.  Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.

Authors:  B Gumbiner; K S Polonsky; W F Beltz; K Griver; P Wallace; G Brechtel; R R Henry
Journal:  J Clin Endocrinol Metab       Date:  1990-06       Impact factor: 5.958

Review 8.  Benefits and limitations of very-low-calorie diet therapy in obese NIDDM.

Authors:  R R Henry; B Gumbiner
Journal:  Diabetes Care       Date:  1991-09       Impact factor: 19.112

9.  Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss.

Authors:  G R Freidenberg; D Reichart; J M Olefsky; R R Henry
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  2 in total

1.  Sertraline enhances the effects of cognitive-behavioral treatment on weight reduction of obese patients.

Authors:  V Ricca; E Mannucci; M Di Bernardo; S M Rizzello; P L Cabras; C M Rotella
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

2.  The Prevention Of WEight Regain in diabetes type 2 (POWER) study: the effectiveness of adding a combined psychological intervention to a very low calorie diet, design and pilot data of a randomized controlled trial.

Authors:  Kirsten A C Berk; Hanneke Buijks; Behiye Ozcan; Adriaan Van't Spijker; Jan J V Busschbach; Eric J G Sijbrands
Journal:  BMC Public Health       Date:  2012-11-23       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.